Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Equity Ratio (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Equity Ratio for 14 consecutive years, with 0.38 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 19.79% year-over-year to 0.38, compared with a TTM value of 0.38 through Dec 2025, up 19.79%, and an annual FY2025 reading of 0.23, down 32.59% over the prior year.
  • Equity Ratio was 0.38 for Q4 2025 at Enanta Pharmaceuticals, up from 0.23 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.93 in Q1 2021 and bottomed at 0.23 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.6, with a median of 0.47 recorded in 2023.
  • The sharpest move saw Equity Ratio crashed 51.32% in 2024, then increased 19.79% in 2025.
  • Year by year, Equity Ratio stood at 0.87 in 2021, then fell by 0.78% to 0.87 in 2022, then plummeted by 48.27% to 0.45 in 2023, then fell by 28.38% to 0.32 in 2024, then grew by 19.79% to 0.38 in 2025.
  • Business Quant data shows Equity Ratio for ENTA at 0.38 in Q4 2025, 0.23 in Q3 2025, and 0.26 in Q2 2025.